NURIX THERAPEUTICS, INC. (NRIX) Operating income 2019–2025
NURIX THERAPEUTICS, INC. (NRIX) annual operating income history from SEC filings — each fiscal year as reported.
-$285.7MFY2025 · since FY2019: -$22.2M → -$285.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$285.7M | -34.1% |
| FY2024 | -$213.0M | -37.4% |
| FY2023 | -$155.1M | +15.7% |
| FY2022 | -$183.9M | -56.0% |
| FY2021 | -$117.9M | -81.4% |
| FY2020 | -$65.0M | -192.2% |
| FY2019 | -$22.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More NRIX financial trends
NRIX RevenueNRIX Net incomeNRIX Net marginNRIX Gross profitNRIX Gross marginNRIX Operating marginNRIX Operating cash flowNRIX Free cash flowNRIX Capital expendituresNRIX Return on equityNRIX Stock buybacksNRIX Dividends paidNRIX Total assetsNRIX Total liabilitiesNRIX Shareholders’ equityNRIX overview →